Form D · Other Technology
Rethink Autism, Inc.
New York, NY · CIK 0001433164
Offering snapshot reported Jun 3, 2014 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2014 | Initial | $10,000,000 | No comparison | 3 | SEC filing |
| Oct 18, 2011 | Amendment | $3,115,000 | $100,000vs Aug 10, 2011 | 9 | SEC filing |
| Aug 10, 2011 | Amendment | $3,015,000 | $500,000vs Apr 27, 2011 | 7 | SEC filing |
| Apr 27, 2011 | Initial | $2,515,000 | No comparison | 6 | SEC filing |
| Apr 20, 2010 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Apr 16, 2010 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Dec 4, 2009 | Initial | $600,000 | No comparison | 2 | SEC filing |
| Oct 14, 2009 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Sep 14, 2009 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jul 17, 2009 | Initial | $410,000 | No comparison | 1 | SEC filing |
| Apr 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-218453
Source: Form D, filed Jun 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Etra | Director, Executive |
| Zubin Mehta | Director |
| Eran Rosenthal | Director, Executive |
| Gregory Shalov | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
19 West 21 St Street Suite 403
New York, NY, 10010
New York, NY, 10010